[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100337684":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":10,"locations":25,"responsibleParty":46,"collaborators":48,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":10,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":60,"maxAge":10,"enrollmentInfo":61,"targetDuration":10,"studyType":64,"phases":10,"briefSummary":65,"conditions":66,"keywords":10,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"City of Hope Medical Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Diagnostic (biospecimen collection)",null,"Previously collected FNA aspiration specimen samples are analyzed via DDMS assay. Participants undergo FNA aspiration for collection of tissue samples for analysis via DDMS assay.",[13],"Other: Diagnostic DNA Methylation Signature",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"Diagnostic DNA Methylation Signature","Undergo collection of tissue samples",[9],[20],"DDMS",[22],{"name":23,"affiliation":5,"role":24},"Maria Hahn, PhD","PRINCIPAL_INVESTIGATOR",[26],{"facility":5,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"RECRUITING","Duarte","California","91010","United States","US",{"type":34,"coordinates":35},"Point",[36,37],-117.97729,34.13945,{"lat":37,"lon":36},[40,44],{"name":23,"role":41,"phone":42,"phoneExt":10,"email":43},"CONTACT","626-256-4673","mhahn@coh.org",{"name":45,"role":24,"phone":10,"phoneExt":10,"email":10},"Maria Hahn",{"type":47,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[49],{"name":50,"class":51},"National Cancer Institute (NCI)","NIH","100337684","diagnostic-dna-methylation-signature-in-diagnosing-thyroid-cancer-after-fine-needle-aspiration-in-patients-with-thyroid-nodules-100337684",false,"NCT03676647","Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules","Retrospective-Prospective Collection of Thyroid Specimens After FNA","Inclusion Criteria:\n\n* All patients undergoing FNA for thyroid nodule diagnosis.\n* Any race and ethnicity are eligible for the study.\n* Patient should have thyroid nodule(s) with indeterminate diagnosis after FNA (Bethesda category of indeterminate FNA \\[III-V\\]).","ALL","19 Years",{"count":62,"type":63},22,"ESTIMATED","OBSERVATIONAL","This trial studies how well the diagnostic deoxyribonucleic acid (DNA) methylation signature works in detecting thyroid cancer in patients with thyroid nodules. Using diagnostic testing, such as the diagnostic DNA methylation signature, may be a less invasive way to check for thyroid cancer.",[67],"Thyroid Gland Nodule","2026-06-01",{"date":70,"type":71},"2026-06-02","ACTUAL",{"date":73,"type":63},"2027-01-01",{"date":75,"type":63},"2028-09-25",{"name":5,"class":6},1]